Pulitzer Prize-winning NYTimes Opinion columnist Tom Friedman shares his perspective on the United States’ indefinite involvement in Venezuela. He warns that without a pathway toward functioning democracy, the country’s “mafia leadership” may remain in place. President Trump is speaking out against defense company stock dividends and buybacks. Plus, Becky Quick shares her personal connection to CNBC’s newest initiative, CNBC Cures. In a conversation with former FDA Commissioner Dr. Scott Gottlieb, she discusses the scale of rare diseases and the regulatory hurdles that impact treatments for diagnoses like that of her own daughter, Kaylie. Join us in advancing awareness and understanding of rare diseases. Listen to The Path with Becky Quick, and visit CNBC.com/Cures to access clips, resources, or to sign up for our weekly newsletter.

Tom Friedman - 13:05

Dr. Scott Gottlieb - 26:06

In this episode:

Becky Quick, @BeckyQuick

Joe Kernen, @JoeSquawk

Andrew Ross Sorkin, @andrewrsorkin

Katie Kramer, @Kramer_Katie

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

It's the story Becky Quick never thought she would tell. Her own.

As a mom to a child with a rare genetic disease, Squawk Box co-host Becky Quick dove into the hidden world of the many ways biological chance can change our lives. Thirty million Americans have a rare disease, which impact small numbers of patients. Two-thirds of those thirty million are children; 95% of rare diseases don’t have an FDA-approved treatment. But despite those eye-popping numbers, millions of people continue to suffer from diseases that often go overlooked by the broader healthcare industry. Small patient populations mean drug companies and investors aren’t willing to invest in the space, and outdated regulatory frameworks make the process of developing lifesaving treatments too slow for the families that need them.

Becky and her husband Matt Quayle share the journey of their 9-year old daughter Kaylie, who has a rare genetic condition called SYNGAP-1. Over the next several episodes of The Path, Becky will highlight the unique challenges faced by millions of Americans, put a spotlight on the bottlenecks slowing progress in the rare disease space, and talk with stakeholders who have the power to bring about change.

Join us in advancing awareness and understanding of rare diseases. Visit CNBC.com/Cures to access clips, resources, or to sign up for our weekly newsletter.

Follow Becky Quick on X: @BeckyQuick

Please share your thoughts or rare disease story in the comments, and join us on The Path.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

CNBC’s Eamon Javers and Brian Sullivan report on the flow of Venezuelan oil to the United States. Venezuela will give the U.S. sanctioned oil indefinitely, that oil will be sold to American oil companies, and the proceeds will be held in American banks until the President determines it can be returned to Venezuela. The other geopolitical headline today: the future of Greenland. While the State Department and President Trump have issued slightly different statements on the prospect of acquiring the country from Denmark, questions about implications for NATO remain. Plus, after MSNow Senior Political and National reporter Jacob Soboroff covered the LA fires last year, he wrote “Firestorm: The Great Los Angeles Fires and America’s New Age of Disaster.” He shares details of the devastation, the road to rebuilding LA, and his personal stake in the community that was impacted.

Eamon Javers - 2:55

Brian Sullivan - 13:51

Jacob Soboroff - 29:19

In this episode:

Eamon Javers, @eamonjavers

Brian Sullivan, @SullyCNBC

Jacob Soboroff, @jacobsoboroff

Becky Quick, @BeckyQuick

Joe Kernen, @JoeSquawk

Andrew Ross Sorkin, @andrewrsorkin

Cameron Costa, @CameronCostaNY

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.